Back to User profile » Dr Zengwu Shao

Papers published by Dr Zengwu Shao:


Prognostic Value of the Preoperative Lymphocyte-to-C-Reactive Protein Ratio and Albumin-to-Globulin Ratio in Patients with Osteosarcoma

Hu H, Deng X, Song Q, Lv H, Chen W, Xing X, Zhu J, Tan Z, Cheng X, Wang B, Shao Z, Zhang Y

OncoTargets and Therapy 2020, 13:12673-12681

Published Date: 9 December 2020

The Personalized Shoulder Reconstruction Assisted by 3D Printing Technology After Resection of the Proximal Humerus Tumours

Hu H, Liu W, Zeng Q, Wang S, Zhang Z, Liu J, Zhang Y, Shao Z, Wang B

Cancer Management and Research 2019, 11:10665-10673

Published Date: 23 December 2019

Lycorine exerts antitumor activity against osteosarcoma cells in vitro and in vivo xenograft model through the JAK2/STAT3 pathway

Hu H, Wang S, Shi D, Zhong B, Huang X, Shi C, Shao Z

OncoTargets and Therapy 2019, 12:5377-5388

Published Date: 8 July 2019

Prognostic and clinicopathological significance of DEPTOR expression in cancer patients: a meta-analysis

Hu B, Shi D, Lv X, Wu F, Chen S, Shao Z

OncoTargets and Therapy 2018, 11:5083-5092

Published Date: 22 August 2018

Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway

Hu B, Lv X, Gao F, Chen S, Wang S, Qing X, Liu J, Wang B, Shao Z

OncoTargets and Therapy 2017, 10:4379-4391

Published Date: 8 September 2017